Oral antithrombotic use among myocardial infarction patientsVAN DER ELST, Menno E; CISNEROS-GONZALEZ, Nelly; DE BLAEY, Cornelis J et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 143-146, issn 1060-0280, 4 p.Article

Pharmacogenetics of oral anticoagulantsDALY, Ann K; KING, Barry P.Pharmacogenetics (London). 2003, Vol 13, Num 5, pp 247-252, issn 0960-314X, 6 p.Article

Influenza vaccination in patients on long-term anticoagulant therapyIORIO, A. M; CAMILLONI, B; BASILEO, M et al.Vaccine. 2006, Vol 24, Num 44-46, pp 6624-6628, issn 0264-410X, 5 p.Article

Model predictive control for optimal oral anticoagulant drug administrationPANNOCCHIA, Gabriele; BRAMBILLA, Alessandro.AIChE journal. 2006, Vol 52, Num 9, pp 3315-3320, issn 0001-1541, 6 p.Article

Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with Iow-molecular-weight heparinGEROTZIAFAS, Grigoris T; DUPONT, Charlotte; SPYROPOULOS, Alex C et al.Thrombosis and haemostasis. 2009, Vol 102, Num 1, pp 42-48, issn 0340-6245, 7 p.Article

Overview of Direct Thrombin Inhibitors in Clinical PracticeBOUNAMEAUX, Henri.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 12-17, issn 0094-6176, 6 p., SUP1Article

Oral-anticoagulant-related intracerebral hemorrhagePUNTHAKEE, Xerxes; DOOBAY, Jaya; ANAND, Sonia S et al.Thrombosis research. 2002, Vol 108, Num 1, pp 31-36, issn 0049-3848, 6 p.Article

Usefulness of a second temporary vena cava filter for preventing acute pulmonary thromboembolismISHIKAWA, Tetsuya; OKABE, Teruo; OGAWA, Kazuo et al.Circulation journal. 2003, Vol 67, Num 8, pp 718-720, issn 1346-9843, 3 p.Article

Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?DOUKETIS, James D.Thrombosis research. 2011, Vol 127, Num 6, pp 513-517, issn 0049-3848, 5 p.Article

The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapyPCHELINA, Sofya N; SIROTKINA, Olga V; TARASKINA, Anastasiya E et al.Thrombosis research. 2005, Vol 115, Num 3, pp 199-203, issn 0049-3848, 5 p.Article

A prospective controlled study of a computer-assisted acenocoumarol dosage programMARCO, Fernando; SEDANO, Carmen; BERMUDEZ, Arancha et al.Pathophysiology of haemostasis and thrombosis (Print). 2003, Vol 33, Num 2, pp 59-63, issn 1424-8832, 5 p.Article

Matrix Gla-protein : The calcification inhibitor in need of vitamin K : Vitamin K-dependent proteins: Functions in blood coagulation and beyondSCHURGERS, Leon J; CRANENBURG, Ellen C. M; VERMEER, Cees et al.Thrombosis and haemostasis. 2008, Vol 100, Num 4, pp 593-603, issn 0340-6245, 11 p.Article

Vitamin K : The coagulation vitamin that became omnipotentCRANEHBURG, Ellen C. M; SCHURGERS, Leon J; VERMEER, Cees et al.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 120-125, issn 0340-6245, 6 p.Article

Fucosylated chondroitin sulfate as a new oral antithrombotic agentFONSECA, Roberto J. C; MOURAO, Paulo A. S.Thrombosis and haemostasis. 2006, Vol 96, Num 6, pp 822-829, issn 0340-6245, 8 p.Article

Transition to an oral anticoagulant in patients with heparin-induced thrombocytopeniaBARTHOLOMEW, John R.Chest. 2005, Vol 127, Num 2, pp 27S-34S, issn 0012-3692, SUPArticle

Reversing the new oral anticoagulants with prothrombin complex concentrates (PCCs): what is the evidence?DICKNEITE, Gerhard; HOFFMAN, Maureane.Thrombosis and haemostasis. 2014, Vol 111, Num 2, pp 189-198, issn 0340-6245, 10 p.Article

Weaknesses in the classification criteria for antithrombotic-related major bleeding eventsLAGOR, Charles; ELLIOTT, C. Gregory; STODDARD, Gregory J et al.Thrombosis and haemostasis. 2005, Vol 94, Num 5, pp 997-1003, issn 0340-6245, 7 p.Article

Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case―control study in a large population-based German databaseJOBSKI, Kathrin; BEHR, Sigrid; GARBE, Edeltraut et al.European journal of clinical pharmacology. 2011, Vol 67, Num 9, pp 941-951, issn 0031-6970, 11 p.Article

Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patientsBACHLEITNER-HOFMANN, Thomas; GRUMBECK, Elke; GISSLINGER, Heinz et al.Thrombosis research. 2003, Vol 112, Num 4, pp 229-232, issn 0049-3848, 4 p.Article

Adherence to guidelines and mortality in atrial fibrillationDIEZ-MANGLANO, Jesús; GOMES-MARTIN, Javier; AL-CHEIKH-FELICES, Patricia et al.International journal of cardiology. 2014, Vol 176, Num 2, pp 430-436, issn 0167-5273, 7 p.Article

Efficacy of Low-molecular-weight-heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults : A systematic review of randomized controlled trialsLOUZADA, Martha L; MAJEED, Habeeb; WELLS, Philip S et al.Thrombosis research. 2009, Vol 123, Num 6, pp 837-844, issn 0049-3848, 8 p.Article

Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinationsBOEHLEN, Francoise; REBER, Guido; DE MOERLOOSE, Philippe et al.Thrombosis research. 2005, Vol 115, Num 1-2, pp 131-134, issn 0049-3848, 4 p.Article

A NEW ERA OF ANTICOAGULATIONHAINAUT, P. H.Acta clinica belgica (English ed.). 2012, Vol 67, Num 6, pp 394-398, issn 1784-3286, 5 p.Article

Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonBEINEMA, Maarten; BROUWERS, Jacobus R. B. J; SCHALEKAMP, Tom et al.Thrombosis and haemostasis. 2008, Vol 100, Num 6, pp 1052-1057, issn 0340-6245, 6 p.Article

No impact of factor IX Ala-10 mutations in acenocoumaroltreated southern EuropeansTASSIES, Dolors; MONTEAGUDO, Joan; MARAGALL, Santiago et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 8, pp 563-566, issn 0957-5235, 4 p.Article